Donor–recipient genetic diversity: the role ofpharmacogenomics in kidney transplantation

Author： Brunet Mercè   Millán Olga   Martorell Jaume  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.12, 2013-09, pp. : 1369-1372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tofacitinib in kidney transplantation

By Wojciechowski David  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 9, 2013-09 ,pp. : 1193-1199

Informa Healthcare

Access to resources Recommend Favorite

Anesthetic Pharmacology for Kidney Transplantation

By  

Current Clinical Pharmacology, Vol. 10, Iss. 1, 2015-04 ,pp. : 47-53

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Age on Rejection in Kidney Transplantation

By de Fijter Johan W.  

Drugs & Aging, Vol. 22, Iss. 5, 2005-01 ,pp. : 433-449

Adis International

Access to resources Recommend Favorite

Efficacy and safety of basiliximab in kidney transplantation

By Boggi Ugo   Vistoli Fabio   Signori Stefano   Del Chiaro Marco   Amorese Gabriella   Barsotti Massimiliano   Rizzo Gaetano   Marchetti Piero   Danesi Romano   Del Tacca Mario   Mosca Franco  

Expert Opinion on Drug Safety, Vol. 4, Iss. 3, 2005-05 ,pp. : 473-490

Informa Healthcare

Access to resources Recommend Favorite

Emerging Immunosuppressive Drugs in Kidney Transplantation

By  

Current Clinical Pharmacology, Vol. 6, Iss. 2, 2011-05 ,pp. : 130-136

Bentham Science Publishers

Access to resources Recommend Favorite